DE60040010D1 - Ein Verfahren zum Auffinden vom Prostatakrebs - Google Patents

Ein Verfahren zum Auffinden vom Prostatakrebs

Info

Publication number
DE60040010D1
DE60040010D1 DE60040010T DE60040010T DE60040010D1 DE 60040010 D1 DE60040010 D1 DE 60040010D1 DE 60040010 T DE60040010 T DE 60040010T DE 60040010 T DE60040010 T DE 60040010T DE 60040010 D1 DE60040010 D1 DE 60040010D1
Authority
DE
Germany
Prior art keywords
prostate cancer
seq
subject
cellular component
finding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60040010T
Other languages
German (de)
English (en)
Inventor
Robert H Getzenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Application granted granted Critical
Publication of DE60040010D1 publication Critical patent/DE60040010D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60040010T 1999-10-15 2000-10-16 Ein Verfahren zum Auffinden vom Prostatakrebs Expired - Fee Related DE60040010D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/418,839 US6617432B1 (en) 1999-10-15 1999-10-15 Nuclear matrix proteins polynucleotide sequences encoding them and their use
PCT/US2000/028498 WO2001029218A2 (en) 1999-10-15 2000-10-16 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use

Publications (1)

Publication Number Publication Date
DE60040010D1 true DE60040010D1 (de) 2008-10-02

Family

ID=23659754

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60040010T Expired - Fee Related DE60040010D1 (de) 1999-10-15 2000-10-16 Ein Verfahren zum Auffinden vom Prostatakrebs

Country Status (8)

Country Link
US (3) US6617432B1 (enExample)
EP (2) EP1228210B1 (enExample)
JP (1) JP2003512391A (enExample)
AT (1) ATE405646T1 (enExample)
AU (1) AU784404B2 (enExample)
CA (1) CA2387864A1 (enExample)
DE (1) DE60040010D1 (enExample)
WO (1) WO2001029218A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
JP4560314B2 (ja) * 2004-03-17 2010-10-13 ジェイファーマ株式会社 中性アミノ酸トランスポーターによる癌の検出法、及びそのためのキット

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308835A (en) * 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
US5273877A (en) * 1985-12-24 1993-12-28 Massachusetts Institute Of Technology Non-histological cell type determination
US4882268A (en) * 1985-12-24 1989-11-21 Massachusetts Institute Of Technology Method for determining tissue of origin and degree of malignancy of tumor cells
DE4012454C1 (enExample) * 1990-04-19 1991-08-08 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V., 8000 Muenchen, De
CA2122473C (en) * 1991-10-31 2001-01-23 Lee Anne Beausang Nuclear matrix protein fluid assay
CA2138807A1 (en) 1992-06-22 1994-01-06 Gary Toukatly Novel malignant cell type markers of the interior nuclear matrix
JPH08508396A (ja) * 1993-02-09 1996-09-10 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 核マトリックスタンパク質
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
AUPM885194A0 (en) * 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
AU7394296A (en) * 1995-10-19 1997-05-07 Bristol-Myers Squibb Company Monoclonal antibody br110 and uses thereof
AU7474696A (en) 1995-11-03 1997-05-22 Robert R. Bahnson Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use

Also Published As

Publication number Publication date
ATE405646T1 (de) 2008-09-15
WO2001029218A3 (en) 2002-03-07
EP1228210B1 (en) 2008-08-20
AU1570301A (en) 2001-04-30
CA2387864A1 (en) 2001-04-26
EP1702984A3 (en) 2006-10-18
EP1228210A2 (en) 2002-08-07
AU784404B2 (en) 2006-03-30
EP1702984A2 (en) 2006-09-20
US6617432B1 (en) 2003-09-09
US20030170754A1 (en) 2003-09-11
WO2001029218A2 (en) 2001-04-26
US20050181418A1 (en) 2005-08-18
JP2003512391A (ja) 2003-04-02

Similar Documents

Publication Publication Date Title
DE69841102D1 (de) Monoklonaler antikörper gegen ein prion protein und dessen verwendung zum nachweis von prionen
DE50003766D1 (de) Verfahren und vorrichtung zum nachweis und zur quantifizierung von biomolekülen
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
DE69932813D1 (de) Nukleinsäurebindungsproteine
DK1625163T3 (da) Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43
DE60237455D1 (de) Verfahren zur quantifizierung von denaturiertem lipoprotein
ATE325344T1 (de) Zielsequenzen für synthetische moleküle und verfahren für deren verwendung
DE60044420D1 (de) Enzym-Protein-Komplex
WO2000035950A3 (en) Reagents and methods useful for detecting diseases of the breast
AU1259801A (en) Detection method by pcr
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
EP1428835A4 (en) ANTIBODY AND ITS USE
ATE316577T1 (de) Das goodpasture-antigen bindende protein
MX9804459A (es) Procedimiento para el diagnostico y terapia de epitelioma.
DE60040010D1 (de) Ein Verfahren zum Auffinden vom Prostatakrebs
DE50207801D1 (de) Verfahren zum Nachweis prokaryontischer DNA
FI885312L (fi) Menetelmä spesifisesti sitovan proteiinin ja vastaavan sidottavan aineen välisen reaktion yhden tai useamman komponentin määrittämiseksi koenäytteestä käyttäen ainakin yhtä leimattua komponenttia, menetelmä leimatun komponentin valmistamiseksi sekä koepakkaus.......
ATE462975T1 (de) Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers
ATE284034T1 (de) Verfahren zum nachweis von protein s
DE69817338D1 (de) Verfahren zum nachweis von autoimmun-pathologien
DK0923644T3 (da) G-koblet receptor, der udviser selektiv selektivitet for ATP
WO2004074446A3 (en) Parkin interacting polypeptides and methods of use

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee